Navigation Links
SHL to Invest 40 Million USD in 2013 to Significantly Expand Production Facilities
Date:2/25/2013

Taoyuan, Taiwan (PRWEB) February 25, 2013

SHL announced plans this week to expand production facilities in Taiwan. A leader in the field of drug delivery devices such as auto injectors and pen injectors, SHL has continued to invest heavily in facilities, advanced machinery and R&D. With the rapid growth of the biologic injectable market, device suppliers are under pressure to broaden the range of services that they can provide. SHL has responded by making significant capital investments such as the 40 Million USD that will be spent this year alone.

CEO Roger Samuelsson commented, “Five years ago I signed a letter of intent with the Taiwan government promising to invest 100 Million USD here. We kept our promise and even completed that investment early. Now we will spend another 40 Million USD for 2013. Our auto injector business is one of the key drivers to this expansion of production capacity. Our customers are bringing more biologics to market and SHL is going to ensure that we meet their needs.”

This year SHL will invest primarily in molding, material handling, assembly and automation capabilities. Production will be ramped up at several facilities in Taiwan, Taoyuan One and various NanKan sites. Increased capacity will allow SHL the flexibility to provide higher quantities of devices each month. In addition to auto injectors, SHL produces pen injectors, infusors and inhaler systems. The company now has well over 2,200 staff globally and will be hiring several hundred new employees in Taiwan this year.

About SHL

SHL is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices. We have over 2,200 staff globally, with our primary design centers located in the USA and Sweden and manufacturing centers located in Asia.

SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. FibeRio® Technology Corporation Announces Strategic Investment Financing Led by SABIC and Aster Capital
2. VIC Investor Network to Significantly Accelerate Technology Company Growth
3. INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research with Seed Round Investment in Sanguine BioSciences
4. PDL BioPharma to Present at Two Upcoming Investor Conferences
5. Oramed Pharmaceuticals Moves Forward with Investigational New Drug Application for Oral Insulin
6. Keryx Biopharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference Presentation Scheduled for Monday, February 11th at 2:30 PM ET
7. Amarantus BioScience to Present at the 15th Annual BIO CEO & Investor Conference
8. Palatin Technologies, Inc. to Present at 15th Annual BIO CEO & Investor Conference
9. EastBridge Investment Group Announces Completion of its Merger with Cellular Biomedicine Group - Shareholder Conference Call to be held February 8th
10. Patheon Announces First Phase of Additional Investment in Milton Park, UK Facility to Expand Early Development Capabilities in Europe
11. Infinata's BioPharm Clinical™ to Present Session on Improving Investigator Selection at CHI’s Summit for Clinical Operations (SCOPE) on February 6 in Miami, FL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 2014 Two separate delegations of ... by Charm Sciences at its Andover, Massachusetts facility ... the US, the participants discussed international systems for ... and process verification, and received hands-on technical training ... the first visit to the United States for ...
(Date:10/31/2014)... The report "Dairy Alternative (Beverage) ... Flavored, Sweetened, Unsweetened), Channel (Supermarket, Health Store, Pharmacy, ... Forecast to 2018," defines and segments the dairy ... of revenue and volume for plant-based dairy alternative ... reach $14 Billion by 2018 with the Asia-Pacific ...
(Date:10/31/2014)... , Oct. 31, 2014  Tavistock Development Co. ... Tavistock Group, celebrated the groundbreaking of the GuideWell ... The 92,000-square-foot, three-story facility is ... Florida designed specifically for life sciences, ... heart of the 650-acre Lake Nona Medical City, ...
(Date:10/30/2014)...  Ardelyx, Inc. (NASDAQ: ARDX ), ... and metabolic diseases, today announced that it will ... November 6, 2014. Following the announcement, the Ardelyx ... and webcast at 4:30pm ET to review the ... The live webcast can be accessed ...
Breaking Biology Technology:Charm Sciences Hosts Executives from Latin America for Dairy Safety Executive Seminar 2Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 2Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 3Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 4GuideWell Innovation Center Groundbreaking Hosted by Tavistock Development Company at Lake Nona Medical City 2GuideWell Innovation Center Groundbreaking Hosted by Tavistock Development Company at Lake Nona Medical City 3Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014 2
... Expedites Reporting Process, WALL, N.J., Oct. 24 ... leader in wireless public safety,solutions and finger based ... from the Littleton, Colorado Police Department,to implement the ... is a module of BIO-key,s Mobile Office(TM) solution. ...
... SAN FRANCISCO, Oct. 24 Cell Therapeutics,Inc. ... data presented at,the 19th annual AACR-NCI-EORTC Symposium ... kill tumors refractory to currently,marketed platinum agents ... human clinical trials in late 2008. ...
... (Nasdaq: KERX ) will hold a conference call ... discuss the Third Quarter 2007 financial results.,Michael S. Weiss, ... the call. Keryx will announce its financial results for ... to the call. In order to participate in ...
Cached Biology Technology:BIO-key(R) Awarded Contract to Deploy Incident Reporting System for Littleton, CO Police Department 2First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs 2First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs 3Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT 2
(Date:10/30/2014)... German . ... to behave socially? This is one of the central ... studies assumed that it is almost impossible to control ... Planck Institute for Evolutionary Biology have now demonstrated that ... cooperative behaviour of others. However, the possibilities available to ...
(Date:10/30/2014)... 29, 2014  Securus Technologies, a leading ... solutions for public safety, investigation, corrections and ... exciting enhancements to its THREADS™ product, which ... actionable intelligence and focused leads for investigators. ... technological innovation through identifying and delivering solutions ...
(Date:10/29/2014)... open for the Society of Interventional Radiology,s ... is the one place where interventional radiologists, ... care professionals can come together to find ... being presented, discussed and tested. , ... image-guided medicine, SIR 2015 will feature essential ...
Breaking Biology News(10 mins):Together we are strong -- or insufferable 2Together we are strong -- or insufferable 3Together we are strong -- or insufferable 4Securus Technologies Adds Advanced Features to Its Industry-Leading Investigative Analytics Product 2SIR 2015: Interventional radiology shapes tomorrow's medicine 2
... Tenn. Consider the case of the three-spine stickleback. ... fresh water might appear to be the same, yet ... collection of very specialized individuals. Understanding the ... the goal of a group of scientists meeting at ...
... Stephania Cormier, PhD, Associate Professor of Pharmacology ... shown for the first time that early exposure ... ultrafine particulate matter) affects long-term lung function. She ... 11th International Congress on Combustion By-Products and Their ...
... research that allows farmers to harvest rice earlier, giving them ... needed food and ease hunger during monga -- the hunger ... northwest Bangladesh from September to November after the previous season,s ... rice in December. According to the Bangladesh Bureau ...
Cached Biology News:The value of variation: Ecologists consider the causes and consequences 2LSUHSC shows for first time infant inhalation of ultrafine air pollution linked to adult lung disease 2Early rice harvests ease annual famine in Bangladesh 2
... Human, Assay, 96 wells. ELISA.Specific for ... complexed MMP-3. No cross-reactivity with MMP-1, -2, ... for use with cell culture supernatant, serum, ... -15 to -30 C. Category: Drug ...
... from different human fetal normal tissues ... available upon request. Customers can ... whole set, and pay 70% of ... Dr. P Set products are for ...
Homo sapiens inhibin, beta B (activin AB beta polypeptide) Antigen: Recombinant Protein(142~254aa)...
Self Closing Forceps...
Biology Products: